Resources

The India Opportunity

IndiPharm: Your Gateway to Clinical Research in India.

The total worldwide R&D spending for pharmaceutical and biotech companies (Pharma) in 2007 was $117 Billion, of which 70% represented development costs. This spending is expected to grow at 11% annually and will be $218 billion in 2013.

IndiPharm Clinical Research Services.  Low Cost Global CRO.  FDA Compliant. To read more... Download PDF  IndiPharm Clinical Research Services.  Low Cost Global CRO.  FDA Compliant.

Podcast

Pharmavoice Podcast

Article

Pharmavoice Article

IndiPharm Clinical Research Services.  Low Cost Global CRO.  FDA Compliant.